Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo

Published:2019-05-18 Issue:8 Volume:98 Page:1905-1918
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Jyotsana Nidhi,Sharma Amit,Chaturvedi Anuhar,Budida Ramachandramouli,Scherr Michaela,Kuchenbauer Florian,Lindner Robert,Noyan Fatih,Sühs Kurt-Wolfram,Stangel Martin,Grote-Koska Denis,Brand Korbinian,Vornlocher Hans-Peter,Eder Matthias,Thol Felicitas,Ganser Arnold,Humphries R. Keith,Ramsay Euan,Cullis Pieter,Heuser Michael

Funder

Horizon 2020

Deutsche Krebshilfe

Deutsches Krebsforschungszentrum

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03713-y.pdf

Reference56 articles.

1. De Kouchkovsky I, Abdul-Hay M (2016) Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J 6(7):e441

2. Coelho T et al (2013) Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med 369(9):819–829

3. Fitzgerald K, White S, Borodovsky A, Bettencourt BR, Strahs A, Clausen V, Wijngaard P, Horton JD, Taubel J, Brooks A, Fernando C, Kauffman RS, Kallend D, Vaishnaw A, Simon A (2017) A highly durable RNAi therapeutic inhibitor of PCSK9. N Engl J Med 376(1):41–51

4. Solomon SD, Adams D, Kristen A, Grogan M, González-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH III, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O (2019) Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis. Circulation 139(4):431–443

5. Lorenzer C, Dirin M, Winkler AM, Baumann V, Winkler J (2015) Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics. J Control Release 203:1–15

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA;Journal of Controlled Release;2024-10

2. Exploring dose and downregulation dynamics in lipid nanoparticles based siRNA therapy: Systematic review and meta-analysis;International Journal of Biological Macromolecules;2024-10

3. mRNA vaccine development and applications: A special focus on tumors (Review);International Journal of Oncology;2024-07-09

4. Nanocarriers: Exploring the Potential of Oligonucleotide Delivery;Current Drug Delivery;2024-06-24

5. A dual gene combination therapy approach by KRAS-G12V gene editing and SLC25A22 gene silencing for KRAS-mutant colorectal cancer;Nano Today;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3